Crystal Structures Of The Human Peroxisome Proliferator-Activated Receptor (Ppar)Alpha Ligand-Binding Domain In Complexes With A Series Of Phenylpropanoic Acid Derivatives Generated By A Ligand-Exchange Soaking Method

Peroxisome proliferator-activated receptor (PPAR)alpha, a member of the nuclear receptor family, is a transcription factor that regulates the expression of genes related to lipid metabolism in a ligand-dependent manner, and has attracted attention as a target for hypolipidemic drugs. We have been developing phenylpropaonic acid derivatives as PPAR alpha-targeted drug candidates for the treatment of metabolic diseases. Recently, we have developed the "ligand-exchange soaking method," which crystallizes the recombinant PPAR alpha ligand-binding domain (LBD) as a complex with intrinsic fatty acids derived from an expression host Escherichia (E.) colt and thereafter replaces them with other higher-affinity ligands by soaking. Here we applied this method for preparation of cocrystals of PPAR alpha LBD with its ligands that have not been obtained with the conventional cocrystallization method. We revealed the high-resolution structures of the cocrystals of PPAR alpha LBD and the three synthetic phenylpropaonic acid derivatives: TIPP-703, APHM19, and YN4pai, the latter two of which are the first observations. The overall structures of cocrystals obtained from the two methods are identical and illustrate the close interaction between these ligands and the surrounding amino acid residues of PPAR alpha LBD. This ligand-exchange soaking method could be applicable to high throughput preparations of co-crystals with another subtype PPAR delta LBD for high resolution X-ray crystallography, because it also crystallizes in complex with intrinsic fatty acid(s) while not in the apo-form.